Upgrading the SACT dataset and EBMT registry to enable outcomes-based reimbursement in oncology in England: a gap analysis and top-level cost estimate

Background: Outcomes-based reimbursement (OBR) can reduce decision uncertainty and accelerate patient access to cell and gene therapies, however, OBR is rarely applied in practice in England. Oncology is the therapy area with the most cell and gene therapies in late-stage development, and the System...

Descripción completa

Detalles Bibliográficos
Autores principales: Jørgensen, Jesper, Kefalas, Panos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609347/
https://www.ncbi.nlm.nih.gov/pubmed/31303982
http://dx.doi.org/10.1080/20016689.2019.1635842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609347/
https://www.ncbi.nlm.nih.gov/pubmed/31303982
http://dx.doi.org/10.1080/20016689.2019.1635842

Ejemplares similares